Have You Heard?

News from the lab, the office—and sometimes the road.

NEWS

Stay Up to Date on FyoniBio

March 20, 2024

FyoniBio collaborates with BioLamina and Alder Therapeutics

FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications FyoniBio, a specialist in tailored cell line...

February 1, 2024

FyoniBio Received CIR Accreditation

FyoniBio Gains CIR Accreditation to Support French Biopharma Companies FyoniBio has been granted CIR (Crédit d’Impôt Recherche) accreditation through 2025, allowing its French partners to...

May 16, 2023

Strike Pharma and FyoniBio Conclude Successfull Cooperation

FyoniBio and Strike Pharma Successfully Complete Cell Line Development for Bi-specific Antibody Clinical Candidate FyoniBio and Strike Pharma announce the successful completion of a key...

May 16, 2023

FyoniBio Launches Its CHOFlow® Cell Line Technology

FyoniBio Introduces CHOFlow® for High-Yield Production of Afucosylated ADCC-Enhanced Antibodies FyoniBio has launched CHOFlow®—a new addition to its tailored cell line portfolio designed to produce...

January 10, 2023

FyoniBio Collaborates with adivo GmbH

FyoniBio and adivo GmbH Sign a Service Agreement Covering the Generation of a Production Cell Line for Their Canine Therapeutic mAb Candidate FyoniBio and adivo...

October 20, 2022

Strike Pharma and FyoniBio Sign a Master Service Agreement

FyoniBio to Develop Production Cell Line for Strike Pharma’s Novel Bi-Specific Antibody FyoniBio and Strike Pharma have signed a Master Service Agreement to advance the...

June 27, 2022

ProteoNic and FyoniBio Sign a License Agreement for Vector Design

ProteoNic Announces Licensing of Its Premium 2G UNic™ Technology Platform for Production of Biologics to FyoniBio FyoniBio has signed a licensing agreement with ProteoNic, gaining...

February 1, 2022

Launch of FyoniBio GmbH

Glycotope to Spin-out Its Service Business to the Newly Formed FyoniBio GmbH As of February 1, 2022, the service business previously operated by Glycotope GmbH...

August 20, 2021

FyoniBio Enters Cooperation with BioGenes

BioGenes and FyoniBio Combine Their Scientific Expertise and Cooperate on Pharmacokinetic and Immunogenicity Analyses. FyoniBio and BioGenes have entered a new collaboration to streamline pharmacokinetic...

Events

Connect with FyoniBio at the Following Events in 2025

Science isn’t static — and neither are we.

You’ll find us at key biotech and pharma events around the world, meeting researchers, exploring new ideas, and talking shop about real-life challenges in biologics development.

Got a project in mind? Stop by our booth, grab a coffee, and let’s talk. Check the list on the right to see where we’ll be next.

The 10th Bioproduction Congress

Lyon, France

22. – 23. September

Festival of Biologics

Basel, Switzerland

30. September – 2. October

BioJapan

Yokohama, Japan

8. – 10. October

Oligonucleotide Therapeutics Society Meeting

Budapest, Hungary

19. – 22. October

Bio Europe

Vienna, Austria

3. – 5. November

PEGS Europe | Protein & Antibody Engineering Summit

Lisbon, Portugal

11. – 13. November

TIDES Europe: Oligonucleotide and Peptide Therapeutics

Basel, Switzerland

11. – 13. November

3rd Annual Clinical Outsourcing Group Europe

Amsterdam, the Netherlands

18. – 19. November

CEO & CFO – Meeting BIO Deutschland

Frankfurt on the Main, Germany

27. – 28. November

We update this section regularly, so feel free to check back from time to time for new materials.

Any questions? Just let us know.